Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers – The filing reports material changes to the company's leadership and/or board composition and related executive compensation matters as of January 6, 2026 Item 8.01: Regulation FD Disclosure – The company is making selective disclosures of…

Our analysis rates this filing NEUTRAL. This 8-K announces a planned executive leadership transition that is being managed in an orderly, deliberate manner. The overall risk profile remains STABLE with a moderate concern score of 3.2/10. While CEO transitions inherently carry execution risk…

Concern level: MODERATE (3.2/10). Key factors: CEO transition introduces execution risk, though mitigated by planned 4-month overlap and internal successor with 25 years tenure; CEO compensation package for successor not yet finalized, requiring future 8-K amendment; Leadership change always carries inherent uncertainty regarding strategic direction and decision-making continuity.

Notable risk changes: Planned CEO succession announced: Lawrence Coben (current CEO/Chair) stepping down April 30, 2026; Robert Gaudette (EVP, NRG Business and Wholesale Operations) named President immediately and CEO effective April 30, 2026; Board appointed Antonio Carrillo (current Lead Independent Director) as successor Chair effective April 30, 2026, indicating orderly governance transition; Transition…

The model predicts NRG will outperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.